» Articles » PMID: 11163210

Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase That Targets the TGF Beta Receptor for Degradation

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2001 Feb 13
PMID 11163210
Citations 562
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitin-mediated proteolysis regulates the activity of diverse receptor systems. Here, we identify Smurf2, a C2-WW-HECT domain ubiquitin ligase and show that Smurf2 associates constitutively with Smad7. Smurf2 is nuclear, but binding to Smad7 induces export and recruitment to the activated TGF beta receptor, where it causes degradation of receptors and Smad7 via proteasomal and lysosomal pathways. IFN gamma, which stimulates expression of Smad7, induces Smad7-Smurf2 complex formation and increases TGF beta receptor turnover, which is stabilized by blocking Smad7 or Smurf2 expression. Furthermore, Smad7 mutants that interfere with recruitment of Smurf2 to the receptors are compromised in their inhibitory activity. These studies thus define Smad7 as an adaptor in an E3 ubiquitin-ligase complex that targets the TGF beta receptor for degradation.

Citing Articles

Long Non-Coding RNAs: Key Regulators of Tumor Epithelial/Mesenchymal Plasticity and Cancer Stemness.

Yuan Y, Tang Y, Fang Z, Wen J, Wicha M, Luo M Cells. 2025; 14(3).

PMID: 39937018 PMC: 11817775. DOI: 10.3390/cells14030227.


Unveiling the role of Pafah1b3 in liver fibrosis: A novel mechanism revealed.

Lin L, Yang S, Li X, Zhang W, Zheng J J Pharm Anal. 2025; 15(1):101158.

PMID: 39906692 PMC: 11791357. DOI: 10.1016/j.jpha.2024.101158.


NPC1 controls TGFBR1 stability in a cholesterol transport-independent manner and promotes hepatocellular carcinoma progression.

Li S, Yan L, Li C, Lou L, Cui F, Yang X Nat Commun. 2025; 16(1):439.

PMID: 39762312 PMC: 11704005. DOI: 10.1038/s41467-024-55788-5.


Efficacy and Mechanism of Alprostadil in Diabetes Mellitus Combined with Peripheral Atherosclerosis.

Yin H, Wan Q Anatol J Cardiol. 2024; .

PMID: 39292156 PMC: 11537455. DOI: 10.14744/AnatolJCardiol.2024.4582.


Advancements in TGF-β Targeting Therapies for Head and Neck Squamous Cell Carcinoma.

Britton W, Cioffi I, Stonebraker C, Spence M, Okolo O, Martin C Cancers (Basel). 2024; 16(17).

PMID: 39272905 PMC: 11394608. DOI: 10.3390/cancers16173047.